MicroDose Technologies
From WikiCover
MicroDose Technologies is a leading privately-held drug delivery and specialty pharmaceuticals company, developing advanced pulmonary, fixed-dose-combination oral dosage, and other technologies for the pharmaceutical and biotechnology industries. MicroDose Technologies creates improved partnered products by combining its proprietary drug delivery technologies with pharmaceutical company compounds, and develops products in-house using its proprietary delivery technologies with generic drug substances.
MicroDose's dry powder inhaler platform is a handheld, low cost, breath activated technology which utilizes piezo electronics to efficiently deliver a broad range of compounds independent of inhalation effort. Partnered programs for the inhaler include; a multi-product development and licensing agreement with Novartis for its proprietary respiratory compounds, and an inhaler for the systemic delivery of a nerve agent antidote for the US Department of Defense in co-development with the University of Pittsburgh. In addition, MicroDose has undisclosed collaborations ongoing with major pharmaceutical partners in the respiratory market segment.
MicroDose's second drug delivery platform, PolyCap, is a fixed-dose-combination oral dosage technology, which allows two or more drugs to be combined in a single capsule, but separated by a physical barrier. Internal development programs utlilizing PolyCap are underway in the areas of diabetes, hypertension and hyperlipidaemia. PolyCap is also available for license to pharmaceutical partners for their combination product needs.
On August 6, 2007, MicroDose announced top line results from a glucose clamp study of the QDose inhaled insulin product. MicroDose, through its joint venture with Vectura Group, QDose Limited, has developed a highly efficient, rapid acting, insulin inhaler, based upon MicroDose's proprietary electronic inhaler technology and Vectura's dry powder insulin formulation. The QDose inhaled insulin product offers dose titration capability over a broad range of dose strengths, in a single inhalation. The inhaler also provides active dose feedbacks to the patient in an easy to use, pocket-sized device.
Headquarters: Monmouth Junction, New Jersey
Website: http://www.microdose-tech.com/